AzTrials
AzTrials

Health Risk BehaviorsNCT05907226

Compare Smokers' Appraisal of Proposed Plain Packs and Existing Cigarette Packs

An observational study of Health Risk Behaviors and Non Communicable Diseases, run by Chinese University of Hong Kong at 1 site in Hong Kong.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

2 Objectives 1. To explore the noticeability of pictorial health warnings and perceptions of attractiveness and harmfulness towards plain cigarette packets and existing cigarette packets with 85% pictorial warnings in current smokers; 2. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
How many people
1,283 participants
Where
1 siteHong Kong
Study dates
4 Jun 2023to 31 Mar 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: At least 1,280 current smokers at smoking hotspots in Hong Kong Island, Kowloon, and the New Territories will be recruited.

Who may be able to join

  • Hong Kong residents aged 18 years and over
  • Able to speak Cantonese or Putonghua
  • Smokers who have tobacco use behaviour of holding a cigarette in the hand or mouth

Who cannot join

  • Foreign domestic helpers
  • Non-smokers

Trial locations and contacts

1 site in 1 country.

Hong Kong1 site
  • The Chinese University of Hong Kong

    Hong Kong

Other trials in Hong Kong

About this study

Official title: Conducting a Study to Compare Smokers' Appraisal of Proposed Plain Packs and Existing Cigarette Packs in Hong Kong

2 Objectives

  1. To explore the noticeability of pictorial health warnings and perceptions of attractiveness and harmfulness towards plain cigarette packets and existing cigarette packets with 85% pictorial warnings in current smokers;
  2. to compare the differences in perceptions of packaging in current smokers with different characteristics (i.e. by sex, age, the consumption level of cigarettes, nicotine dependence levels, and types of tobacco used for polytobacco product users);
  3. to evaluate the effectiveness in reducing smoking consumption and promoting quit attempts; and
  4. to assess the support for the legislation of plain packaging.
Read the detailed description

The present study will recruit at least 1,280 current smokers at smoking hotspots in Hong Kong Island, Kowloon, and the New Territories. Land-based, non-institutionalized Hong Kong residents aged 18 years and over who speak Cantonese or Putonghua are eligible to participate.

Subjects will be shown dummies of branded and plain packets that differ in brand names and plain colours. Subjects will discuss their perceptions of attractiveness and harmfulness, noticeability of warnings and effectiveness in reducing smoking consumption and promoting quit attempts. Their opinions on the legislation of plain packaging will also be asked.

After each interview, interviewers will debrief each interviewee on the harms of smoking and distribute a card providing a quitline and quitting methods.

Keywords
Plain cigarette packs, current smokers, branded cigarette packs
Medical subject headings
Health Risk Behaviors, Noncommunicable Diseases

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percent of participants who perceive current branded packets as attractive

    Perceived attractiveness towards existing cigarette packets with 15 percent brand logo

    Measured: Baseline

  2. Percent of participants who perceive plain packets as harmful

    Perceived harmfulness towards plain packets

    Measured: Baseline

Secondary outcomes (2)
  1. Noticeability of pictorial warnings

    Noticeability of pictorial warnings of plain cigarette packets and existing cigarette packets with 85% pictorial warnings in current smokers will be compared

    Measured: Baseline

  2. Perceived effectiveness

    The effectiveness in reducing smoking consumption and promoting quit attempts

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jun 2023
  2. Study start4 Jun 2023
  3. Primary completion8 Nov 2023
  4. Study completion31 Mar 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
1,283 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05907226
Sponsor's protocol ID
NTEC-2023-179
Status last verified
Aug 2024
First submitted
8 Jun 2023
Last updated
29 Aug 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Health Risk Behaviors and Non Communicable Diseases, run by Chinese University of Hong Kong at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percent of participants who perceive current branded packets as attractive (time frame: Baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in